Health Utilities and Costs for Motor Neurone Disease

Valuing health-related quality of life: An EQ-5D-5L value set for England

Nancy Devlin, Koonal Shah, Yan Feng et al. · Health Economics · 2017 · 1.4K citations · Full text

Social Sciences, Behavioral Sciences, Psychology +17

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

Anthony G Marson, Asya M Al-Kharusi, Muna Alwaidh et al. · The Lancet · 2007 · 970 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

A proposed staging system for amyotrophic lateral sclerosis

J.C. Roche, Ricard Rojas‐García, Kirsten M. Scott et al. · Brain · 2012 · 462 citations · Full text

Medicine, Neurology, Neuroscience +17

An Analysis of Extended Survival in Patients With Amyotrophic Lateral Sclerosis Treated With Riluzole

Marc Rivière, Vincent Meininger, Phillipe Zeisser et al. · Archives of Neurology · 1998 · 199 citations

Medicine, Neurology, Pharmacotherapy +14

Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis

Franco Franchignoni, Gabriele Mora, Andrea Giordano et al. · Journal of Neurology Neurosurgery & Psychiatry · 2013 · 171 citations

Education, Neurology, Neuroscience +17